References
- CrocettoF , di ZazzoE , BuonerbaCet al.Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of the literature. Nutrients13(11), (2021).
- CrozierA , JaganathIB , CliffordMN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep.26(8), 1001–1043 (2009).
- ChenJ , LiG , SunCet al.Chemistry, pharmacokinetics, pharmacological activities, and toxicity of quercitrin. Phytother. Res.36(4), 1545–1575 (2022).
- TarantinoG , CrocettoF , DiVito Cet al.Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study. Future Sci. OA7(3), FSO643 (2021).
- FerroM , de CobelliO , MusiGet al.Radiomics in prostate cancer: an up-to-date review. Ther. Adv. Urol.14, 17562872221109020 (2022).
- MassanovaM , RobertsonS , BaroneBet al.The comparison of imaging and clinical methods to estimate prostate volume: a single-centre retrospective study. Urol. Int.105(9–10), 804–810 (2021).
- FerroM , BabăD-F , de CobelliOet al.Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy. Future Sci. OA7(7), FSO709 (2021).
- BaroneB , CalogeroA , ScafuriLet al.Immune checkpoint inhibitors as a neoadjuvant/adjuvant treatment of muscle-invasive bladder cancer: a systematic review. Cancers (Basel)14(10), (2022).
- IacovinoML , MiceliCC , DeFelice Met al.Novel therapeutic opportunities in neoadjuvant setting in urothelial cancers: a new horizon opened by molecular classification and immune checkpoint inhibitors. Int. J. Mol. Sci.23(3), (2022).
- SteinmausCM , NuñezS , SmithAH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am. J. Epidemiol.151(7), 693–702 (2000).
- CrocettoF , BoccellinoM , BaroneBet al.The crosstalk between prostate cancer and microbiota inflammation: nutraceutical products are useful to balance this interplay?Nutrients12(9), (2020).
- CrocettoF , BaroneB , CaputoVF , FontanaM , de CobelliO , FerroM. BRCA germline mutations in prostate cancer: the future is tailored. Diagnostics (Basel)11(5), (2021).
- Al-ZalabaniAH , StewartKFJ , WesseliusA , ScholsAMWJ , ZeegersMP. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur. J. Epidemiol.31(9), 811–851 (2016).
- HashemzaeiM , DelaramiFar A , YariAet al.Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol. Rep.38(2), 819–828 (2017).
- McCannSE , AmbrosoneCB , MoysichKBet al.Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr. Cancer53(1), 33–41 (2005).
- AdamiBS , DizFM , OliveiraGonçalves GPet al.Morphological and mechanical changes induced by quercetin in human T24 bladder cancer cells. Micron151, 103152 (2021).
- BuonerbaC , DePlacido P , BruzzeseDet al.Isoquercetin as an adjunct therapy in patients with kidney cancer receiving first-line sunitinib (QUASAR): results of a Phase I trial. Front. Pharmacol.9(MAR), (2018).
- ChenF , ChenX , YangDet al.Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways. Oncol. Rep.36(1), 165–172 (2016).
- WooHD , KimJ. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLOS One8(9), e75604 (2013).
- GeybelsMS , VerhageBAJ , ArtsICW , Van SchootenFJ , AlexandraGoldbohm R , VanDen Brandt PA. Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer. Am. J. Epidemiol.177(12), 1388–1398 (2013).